A cataract that has material basis in variation in the region 19q13.
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding cataract 35 is largely due to its extreme rarity, which restricts the scope of systematic clinical studies. As this condition affects fewer individuals, there is less clinical data available to draw upon. Additionally, the genetic basis has not been fully elucidated, making it challenging to characterize the clinical features comprehensively. Ongoing research may help to fill these gaps in understanding.
To navigate your journey with cataract 35, consider seeking a specialist in genetic ophthalmology or a pediatric ophthalmologist with experience in congenital cataracts. These specialists can provide tailored care and management options. Additionally, while no specific patient organizations are identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Exploring clinical trial participation could also provide access to cutting-edge research and potential therapies.
Currently, there is one active clinical trial related to cataract 35. This trial may provide insights into potential management strategies and further understanding of the condition. For more information on the trial, please visit the ClinicalTrials.gov search page: https://clinicaltrials.gov/search?cond=cataract%2035. While there are no orphan drug designations or approved treatments at this time, participation in clinical trials could be a valuable option for affected individuals.
Actionable guidance for navigating care for cataract 35
To navigate your journey with cataract 35, consider seeking a specialist in genetic ophthalmology or a pediatric ophthalmologist with experience in congenital cataracts. These specialists can provide tailored care and management options. Additionally, while no specific patient organizations are identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Exploring clinical trial participation could also provide access to cutting-edge research and potential therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding cataract 35 is largely due to its extreme rarity, which restricts the scope of systematic clinical studies. As this condition affects fewer individuals, there is less clinical data available to draw upon. Additionally, the genetic basis has not been fully elucidated, making it challenging to characterize the clinical features comprehensively. Ongoing research may help to fill these gaps in understanding.
To navigate your journey with cataract 35, consider seeking a specialist in genetic ophthalmology or a pediatric ophthalmologist with experience in congenital cataracts. These specialists can provide tailored care and management options. Additionally, while no specific patient organizations are identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Exploring clinical trial participation could also provide access to cutting-edge research and potential therapies.
Currently, there is one active clinical trial related to cataract 35. This trial may provide insights into potential management strategies and further understanding of the condition. For more information on the trial, please visit the ClinicalTrials.gov search page: https://clinicaltrials.gov/search?cond=cataract%2035. While there are no orphan drug designations or approved treatments at this time, participation in clinical trials could be a valuable option for affected individuals.
Actionable guidance for navigating care for cataract 35
To navigate your journey with cataract 35, consider seeking a specialist in genetic ophthalmology or a pediatric ophthalmologist with experience in congenital cataracts. These specialists can provide tailored care and management options. Additionally, while no specific patient organizations are identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Exploring clinical trial participation could also provide access to cutting-edge research and potential therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding cataract 35 is largely due to its extreme rarity, which restricts the scope of systematic clinical studies. As this condition affects fewer individuals, there is less clinical data available to draw upon. Additionally, the genetic basis has not been fully elucidated, making it challenging to characterize the clinical features comprehensively. Ongoing research may help to fill these gaps in understanding.
To navigate your journey with cataract 35, consider seeking a specialist in genetic ophthalmology or a pediatric ophthalmologist with experience in congenital cataracts. These specialists can provide tailored care and management options. Additionally, while no specific patient organizations are identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Exploring clinical trial participation could also provide access to cutting-edge research and potential therapies.
Currently, there is one active clinical trial related to cataract 35. This trial may provide insights into potential management strategies and further understanding of the condition. For more information on the trial, please visit the ClinicalTrials.gov search page: https://clinicaltrials.gov/search?cond=cataract%2035. While there are no orphan drug designations or approved treatments at this time, participation in clinical trials could be a valuable option for affected individuals.
Actionable guidance for navigating care for cataract 35
To navigate your journey with cataract 35, consider seeking a specialist in genetic ophthalmology or a pediatric ophthalmologist with experience in congenital cataracts. These specialists can provide tailored care and management options. Additionally, while no specific patient organizations are identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Exploring clinical trial participation could also provide access to cutting-edge research and potential therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.